Finding Immune Nascent Type 1 Diabetes

Study acronym: FIND T1D
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 5 more changesShow less
    • Start date changed from estimate of Jun 2026 to Jul 28, 2026
    • Interventions: email/mail (Behavioral), phone call (Behavioral) to email/mail (Behavioral), phone call (Behavioral)
    • Secondary endpoints: 1 to 3
    • Site details revised
    • Eligibility criteria expanded, about 5 words
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Indiana University
313 trials monitored
See 44 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
Type 1 Diabetes
888 trials monitored
See 39 trials at risk
The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.
Trial Details
NCT Number NCT07663136
Lead Sponsor Indiana University
Collaborators: Sanofi
Conditions
(from sponsor)		 Healthy Adult, Type 1 Diabetes (T1D)
Related terms Diabetes Mellitus, Type 1
Enrollment 3,800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov